These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16275050)

  • 1. Chitosan drug binding by ionic interaction.
    Boonsongrit Y; Mitrevej A; Mueller BW
    Eur J Pharm Biopharm; 2006 Apr; 62(3):267-74. PubMed ID: 16275050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles.
    Zheng Y; Wu Y; Yang W; Wang C; Fu S; Shen X
    J Pharm Sci; 2006 Jan; 95(1):181-91. PubMed ID: 16315245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
    Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N
    AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a prolonged-release tablet formulation of diclofenac sodium. Part 1: Using chitosan.
    Acartürk F
    Pharmazie; 1989 Aug; 44(8):547-9. PubMed ID: 2594826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.
    Cerchiara T; Abruzzo A; di Cagno M; Bigucci F; Bauer-Brandl A; Parolin C; Vitali B; Gallucci MC; Luppi B
    Eur J Pharm Biopharm; 2015 May; 92():112-9. PubMed ID: 25769679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation pH modulates the interaction of insulin with chitosan nanoparticles.
    Ma Z; Yeoh HH; Lim LY
    J Pharm Sci; 2002 Jun; 91(6):1396-404. PubMed ID: 12115839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chitosan salts and molecular weight on a nanoparticulate carrier for therapeutic protein.
    Luangtana-anan M; Opanasopit P; Ngawhirunpat T; Nunthanid J; Sriamornsak P; Limmatvapirat S; Lim LY
    Pharm Dev Technol; 2005; 10(2):189-96. PubMed ID: 15926667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing chitosan-dextran sulfate nanoparticles using charge ratios.
    Chen Y; Mohanraj VJ; Wang F; Benson HA
    AAPS PharmSciTech; 2007 Nov; 8(4):E98. PubMed ID: 18181558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
    Gan Q; Wang T
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction.
    Sonvico F; Cagnani A; Rossi A; Motta S; Di Bari MT; Cavatorta F; Alonso MJ; Deriu A; Colombo P
    Int J Pharm; 2006 Oct; 324(1):67-73. PubMed ID: 16973314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a chitosan-based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin.
    Chen Y; Siddalingappa B; Chan PH; Benson HA
    Biopolymers; 2008; 90(5):663-70. PubMed ID: 18655140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
    Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
    Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of drug-chitosan interaction by 1H NMR, FTIR and isothermal titration calorimetry.
    Boonsongrit Y; Mueller BW; Mitrevej A
    Eur J Pharm Biopharm; 2008 May; 69(1):388-95. PubMed ID: 18164928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/methylmethacrylic acid) copolymer.
    Li MG; Lu WL; Wang JC; Zhang X; Zhang H; Wang XQ; Wu CS; Zhang Q
    J Nanosci Nanotechnol; 2006; 6(9-10):2874-86. PubMed ID: 17048494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization.
    Sankalia MG; Mashru RC; Sankalia JM; Sutariya VB
    Eur J Pharm Biopharm; 2007 Feb; 65(2):215-32. PubMed ID: 16982178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
    Krauland AH; Alonso MJ
    Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of physicochemical factors on the release kinetics of hydrophilic drugs from poly(L-lactic acid) (L-PLA) pellets.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):535-9. PubMed ID: 9876619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor.
    Aktaş Y; Andrieux K; Alonso MJ; Calvo P; Gürsoy RN; Couvreur P; Capan Y
    Int J Pharm; 2005 Jul; 298(2):378-83. PubMed ID: 15893439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.